References
- Rao N, Jain A, Goyale A, et al. Lipoprotein X in autoimmune liver disease causing interference in routine and specialist biochemical investigations. Clin Lipidol. Forthcoming.
- MacIntyre N, Harry DS, Pearson AJG. The hypercholesterolaemia of obstructive jaundice. Gut. 1975;16:379–391.10.1136/gut.16.5.379
- Longo M, Crosignani A, Battezzati PM, et al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut. 2002;51:265–269.10.1136/gut.51.2.265
- Chang PY, Lu SC, Su TC, et al. Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. J Lipid Res. 2004;45:2116–2122.10.1194/jlr.M400229-JLR200
- Fei H, Maeda S, Kirii H, et al. Evaluation of two different homogeneous assays for LDL-cholesterol in lipoprotein-X-positive serum. Clin Chem. 2000;46:1351–1356.
- Matsushima K, Sugiuchi H, Anraku K, et al. Differences in reaction specificity toward lipoprotein X and abnormal LDL among 6 homogeneous assays for LDL-cholesterol. Clin Chim Acta. 2015;439:29–37.10.1016/j.cca.2014.09.030
- Futatsugi A, Hidaka E, Kubota N, et al. Abnormal serum total protein measurement by lipoprotein-X in an infant with biliary atresia. Rinsho Byori. 2015;63:1271–1276.
- Sivakumar T, Chaidarun S, Lee HK, et al. Multiple lipoprotein and electrolyte laboratory artifacts caused by lipoprotein X in obstructive biliary cholestasis secondary to pancreatic cancer. J Clin Lipidol. 2011;5:324–328.10.1016/j.jacl.2011.04.004
- Talafant E, Továrek J. Rapid colorimetric methods for quantitative lipoprotein-X determination without electrophoresis. Clin Chim Acta. 1978;88:215–220.10.1016/0009-8981(78)90425-4
- Talafant E, Továrek J. Turbidimetric determination of lipoprotein-X in serum. Clin Chim Acta. 1979;96:261–264.10.1016/0009-8981(79)90437-6
- Talafant E, Továrek J. Enzymatic determination of lipoprotein-X, a specific serum cholestasis marker. J Clin Chem Clin Biochem. 1981;19:155–157.
- Hashiguchi Y, Kawaguchi M, Nakanishi M, et al. Simple, direct measurement of lipoprotein X in serum. Clin Chem. 1982;28:606–608.
- Pattman SJ, Askew B, Neely RD, et al. Detection and quantification of Lp-X in patients with cholestatic jaundice and comparison to those with other causes of dyslipidaemia. Ann Clin Biochem. 2013;50(Suppl 1):73.
- Seidel D, Alaupovic P, Furman RH. A lipoprotein characterising obstructive jaundice. I. A method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Investig. 1969;48:1211–1223.10.1172/JCI106085
- Holmes E, Boot C, Neely D. Familial dysbetalipoproteinaemia (type III hyperlipidaemia) screening using a non-HDL-cholesterol/apoB ratio: reference range determination and comparison with apoB/total cholesterol ratio. Ann Clin Biochem. 2016;53(Suppl 1):26–27.